Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics**
Angewandte Chemie International Edition · 2023
DOI: 10.1002/anie.202308174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Yang Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, …. Hauptthemen laut MEDLINE: Immunoconjugates, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Beijing National Laboratory for Molecular Sciences.
Abstract (Originalsprache)
Glycoengineering has provided powerful tools to construct site‐specific antibody conjugates. However, only small‐molecule payloads can be directly transferred to native or engineered antibodies using existing glycoengineering strategies. Herein, we demonstrate that reducing the complexity of crystallizable fragment (Fc) glycans could dramatically boost the chemoenzymatic modification of immunoglobulin G (IgG) via an engineered fucosyltransferase. In this platform, antibodies with Fc glycans engineered to a simple N‐acetyllactosamine (LacNAc) disaccharide are successfully conjugated to biomacromolecules, such as oligonucleotides and nanobodies, in a single step within hours. Accordingly, we synthesized an antibody‐conjugate‐based anti‐human epidermal growth factor receptor 2 (HER2)/ cluster of differentiation 3 (CD3) bispecific antibody and used it to selectively destroy patient‐derived cancer organoids by reactivating endogenous T lymphocyte cells (T cells) inside the organoid. Our results highlight that this platform is a general approach to construct antibody‐biomacromolecule conjugates with translational values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing, Jiangsu, 210023, Chin…
- Glyco therapy Biotechnology Co., Ltd., 601/606 Building 12, Hangzhou Pharmaceutical Town, 291 Fucheng Road, Xiasha street, Qiantang Distirct, Hangzhou, Zhejiang, 310058, China.
- Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Beijing National Laboratory for Molecular Sciences
Zitieren
APA
Yang, Y., Song, Z., Tian, T., Zhao, Z., Chen, J., Hu, J., Jiang, X., Yang, G., Xue, Q., Zhao, X., Sha, W., Yang, Y., & Li, J. P. (2023). Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics**. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202308174
Vancouver
Yang Y, Song Z, Tian T, Zhao Z, Chen J, Hu J, et al. Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics**. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202308174
BibTeX
@article{Yang2023,
author = {Yang, Yang and Song, Zhentao and Tian, Tian and Zhao, Zihan and Chen, Ji and Hu, Jiangping and Jiang, Xin and Yang, Guoli and Xue, Qi and Zhao, Xinlu and Sha, Wanxing and Yang, Yi and Li, Jie P},
title = {Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics**},
journal = {Angewandte Chemie International Edition},
year = {2023},
doi = {10.1002/anie.202308174}
}
EUVIMED